We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$746M
AUM Growth
-$106M
Cap. Flow
+$120M
Cap. Flow %
16.15%
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
58
Closed
238

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$49.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.8M
3
DIS icon
Walt Disney
DIS
+$16.1M
4
MSFT icon
Microsoft
MSFT
+$11M
5
TSM icon
TSMC
TSM
+$8.27M

Top Sells

Rank Stock Value
1
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$6.55M
2
BHC icon
Bausch Health
BHC
+$5.35M
3
DLR icon
Digital Realty Trust
DLR
+$1.95M
4
PFSI icon
PennyMac Financial
PFSI
+$1.67M
5
COP icon
ConocoPhillips
COP
+$1.62M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.32%
2 Consumer Discretionary 7.31%
3 Communication Services 4.95%
4 Technology 3.75%
5 Energy 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIGA icon
201
SIGA Technologies
SIGA
$218M
$193K 0.03%
+18,700
New +$300K
ADT icon
202
CALL
ADT
ADT
$5.17B
$187K 0.03%
+25,000
New +$188K
XBI icon
203
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.6B
$182K 0.02%
+2,300
New +$194K
SQM icon
204
Sociedad Química y Minera de Chile
SQM
$20B
$182K 0.02%
+2,000
New +$194K
TGTX icon
205
CALL
TG Therapeutics
TGTX
$8.25B
$177K 0.02%
29,900
– –
SNAP icon
206
CALL
Snap
SNAP
$9.88B
$172K 0.02%
17,500
-37,500
-68% -$436K
VTRS icon
207
PUT
Viatris
VTRS
$19.1B
$170K 0.02%
20,000
-10,000
-33% -$98.4K
SGMO
208
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$170K 0.02%
+34,700
New +$178K
SGMO
209
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$161K 0.02%
+32,800
New +$168K
RCEL icon
210
Avita Medical
RCEL
$306M
$156K 0.02%
29,650
-2,350
-7% -$14.5K
MDRX
211
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
$152K 0.02%
+10,000
New +$162K
TELL
212
DELISTED
Tellurian Inc.
TELL
$143K 0.02%
60,000
-15,000
-20% -$54.1K
TELL
213
PUT
DELISTED
Tellurian Inc.
TELL
$143K 0.02%
60,000
– –
MELI icon
214
Mercado Libre
MELI
$96.3B
$142K 0.02%
172
+122
+244% +$105K
VERV
215
DELISTED
Verve Therapeutics
VERV
$137K 0.02%
+4,000
New +$128K
UWMC icon
216
CALL
UWM Holdings
UWMC
$462M
$130K 0.02%
44,400
– –
VTRS icon
217
Viatris
VTRS
$19.1B
$128K 0.02%
15,000
-5,000
-25% -$49.2K
PG icon
218
Procter & Gamble
PG
$339B
$126K 0.02%
+1,000
New +$142K
RCEL icon
219
PUT
Avita Medical
RCEL
$306M
$124K 0.02%
23,500
– –
AR icon
220
PUT
Antero Resources
AR
$11.8B
$122K 0.02%
+4,000
New +$148K
GOSS icon
221
PUT
Gossamer Bio
GOSS
$65.6M
$120K 0.02%
125
-125
-50% -$124K
NNDM
222
Nano Dimension
NNDM
$323M
$120K 0.02%
50,000
– –
SITM icon
223
SiTime
SITM
$19.1B
$118K 0.02%
+1,500
New +$193K
PLYA
224
CALL
DELISTED
Playa Hotels & Resorts
PLYA
$116K 0.02%
20,000
– –
DVA icon
225
CALL
DaVita
DVA
$11.6B
$116K 0.02%
1,400
-9,600
-87% -$842K
7 8
9
10 11

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2022 Portfolio in Review

As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SG3 Management deployed $120M of net new capital in Q3 2022, opening 122 new positions and adding to 34 existing holdings. Its largest new stake was Tesla: 177,200 shares worth $47M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 95% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was LivaNova, an estimated $1.29M trimmed.

  • SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
  • SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
  • SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
  • SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
  • SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
  • SG3 Management opened 122 new positions and closed 238 in Q3 2022.
  • SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.